These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12538167)

  • 1. Prognosis of breast cancer and gene expression profiling using DNA arrays.
    Bertucci F; Houlgatte R; Granjeaud S; Nasser V; Loriod B; Beaudoing E; Hingamp P; Jacquemier J; Viens P; Birnbaum D; Nguyen C
    Ann N Y Acad Sci; 2002 Dec; 975():217-31. PubMed ID: 12538167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer revisited using DNA array-based gene expression profiling.
    Bertucci F; Viens P; Hingamp P; Nasser V; Houlgatte R; Birnbaum D
    Int J Cancer; 2003 Feb; 103(5):565-71. PubMed ID: 12494462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of breast carcinomas using nylon DNA arrays.
    Bertucci F; Loriod B; Nasser V; Granjeaud S; Tagett R; Braud AC; Patrice V; Houlgatte R; Daniel B; Nguyen C
    C R Biol; 2003; 326(10-11):1031-9. PubMed ID: 14744110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
    Bertucci F; Nasser V; Houlgatte R; Birnbaum D
    Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
    Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
    Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.
    Bertucci F; Nasser V; Granjeaud S; Eisinger F; Adelaïde J; Tagett R; Loriod B; Giaconia A; Benziane A; Devilard E; Jacquemier J; Viens P; Nguyen C; Birnbaum D; Houlgatte R
    Hum Mol Genet; 2002 Apr; 11(8):863-72. PubMed ID: 11971868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
    Bertucci F; Borie N; Roche H; Bachelot T; Le Doussal JM; Macgrogan G; Debono S; Martinec A; Treilleux I; Finetti P; Esterni B; Extra JM; Geneve J; Hermitte F; Chabannon C; Jacquemier J; Martin AL; Longy M; Maraninchi D; Fert V; Birnbaum D; Viens P
    Breast Cancer Res Treat; 2011 Jun; 127(2):363-73. PubMed ID: 20585850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
    Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
    JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling technology: its contribution to our understanding of breast cancer.
    Rakha EA; El-Sayed ME; Reis-Filho JS; Ellis IO
    Histopathology; 2008 Jan; 52(1):67-81. PubMed ID: 18171418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.
    Fleischer T; Edvardsen H; Solvang HK; Daviaud C; Naume B; Børresen-Dale AL; Kristensen VN; Tost J
    Int J Cancer; 2014 Jun; 134(11):2615-25. PubMed ID: 24395279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of primary breast carcinomas using arrays of candidate genes.
    Bertucci F; Houlgatte R; Benziane A; Granjeaud S; Adélaïde J; Tagett R; Loriod B; Jacquemier J; Viens P; Jordan B; Birnbaum D; Nguyen C
    Hum Mol Genet; 2000 Dec; 9(20):2981-91. PubMed ID: 11115842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinicopathological markers of prognosis in breast cancer.
    Boyle DP; McCourt CM; Matchett KB; Salto-Tellez M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):481-98. PubMed ID: 23782255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of high-grade tumors in breast cancer gene expression studies.
    van Seijen M; Mooyaart AL; Mulder L; Hoogstraat M; Drukker CA; Loo CE; Pouw B; Sonke GS; Wesseling J; Lips EH
    Breast Cancer Res Treat; 2018 Apr; 168(2):327-335. PubMed ID: 29256013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.